[1]
Deng, Y. et al. 2017. MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1. EXCLI Journal. 16, (May 2017), 618–627. DOI:https://doi.org/10.17179/excli2017-258.